Cost-effectiveness of Voretigene Neparvovec-rzyl Therapy

Nicolas A. Yannuzzi, William E. Smiddy

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
JournalJAMA ophthalmology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Cost-Benefit Analysis
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Cost-effectiveness of Voretigene Neparvovec-rzyl Therapy. / Yannuzzi, Nicolas A.; Smiddy, William E.

In: JAMA ophthalmology, 01.01.2019.

Research output: Contribution to journalComment/debate

@article{4c246ff89df94b4d8d6c52c134631490,
title = "Cost-effectiveness of Voretigene Neparvovec-rzyl Therapy",
author = "Yannuzzi, {Nicolas A.} and Smiddy, {William E.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1001/jamaophthalmol.2019.2517",
language = "English (US)",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",

}

TY - JOUR

T1 - Cost-effectiveness of Voretigene Neparvovec-rzyl Therapy

AU - Yannuzzi, Nicolas A.

AU - Smiddy, William E.

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85069502708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069502708&partnerID=8YFLogxK

U2 - 10.1001/jamaophthalmol.2019.2517

DO - 10.1001/jamaophthalmol.2019.2517

M3 - Comment/debate

C2 - 31318388

AN - SCOPUS:85069502708

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

ER -